- Home
- / NanoViricides
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
NanoViricides financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$1.4
2024-10-29
Market Capitalization
$21.2 M
2024-10-29
CreditSafe Score
?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| General and administrative expense | 1.8M | 2.3M | 3.5M | 3.4M | 3.8M | 4.1M | 4.5M | 2.7M | 3.3M | 2.6M | 2.3M | 2.6M | 3.1M | 4.0M |
| Operating expense total | 6.1M | 6.6M | 8.7M | 7.1M | 8.9M | 9.6M | 9.3M | 8.7M | 8.0M | 8.1M | 8.9M | 8.5M | 9.6M | |
| EBIT | (6.1M) | (6.6M) | (8.7M) | (7.1M) | (8.9M) | (9.6M) | (9.3M) | (8.7M) | (8.0M) | (8.7M) | (8.1M) | (8.9M) | (8.5M) | (9.6M) |
| Interest income | 46.8K | 55.6K | 171.0K | 160.9K | ||||||||||
| Interest expense | 4.9M | 1.9M | 703.8K | 761.7K | 5.1K | 938.0 | 49.8K | |||||||
| Pre tax profit | (6.2M) | (8.9M) | (14.1M) | (2.2M) | (10.7M) | (10.3M) | (8.6M) | (8.4M) | (13.4M) | (8.8M) | (8.1M) | |||
| Net Income | (6.2M) | (8.9M) | (14.1M) | (2.2M) | (10.7M) | (10.3M) | (8.6M) | (8.4M) | (13.4M) | (8.8M) | (8.1M) | (8.6M) | (8.3M) | (9.5M) |
| EPS | (0.7) | (0.7) | (0.6) |